AI supports home-based balance training
Peer-Reviewed Publication
Updates every hour. Last Updated: 21-Dec-2025 08:11 ET (21-Dec-2025 13:11 GMT/UTC)
Balance training patients may soon be able to get AI feedback during home exercises, with four wearable sensors and a new machine learning model developed at the University of Michigan.
Researchers from The University of Osaka found migration of glucose and fructose from the blood to saliva drives oral microbiome dysbiosis in patients with type 2 diabetes, increasing the development of dental caries. This suggests that glycemic control could be an effective strategy for controlling dental caries in this population.
The research team led by Associate Professor Lin-Lin Bu from Wuhan University School and Hospital of Stomatology, has published a comprehensive review entitled “Triaptosis and Cancer: Next Hope?” in the journal Research. This article systematically elaborates the triaptosis pathway from molecular mechanism to therapeutic application, detailing its signaling cascade, discussing the central role of oxidative stress homeostasis in cancer, and offering a forward-looking perspective on future directions—collectively underscoring the compelling potential of triaptosis as a novel anticancer strategy.
A research paper by scientists from Tianjin University proposed a novel solution for high-speed steady-state visually evoked potential (SSVEP)-based brain–computer interfaces (BCIs), featuring a neural principle-based data augmentation technique (BGMix) and a Transformer-based model (AETF) to enhance EEG decoding efficiency.
The new research paper, published on October 7 in the journal Cyborg and Bionic Systems, presented the development, validation, and optimization of the BGMix strategy and AETF model, demonstrating their effectiveness in addressing data sparsity and improving the performance of SSVEP-based BCI systems.Researchers at Martin Luther University Halle-Wittenberg (MLU) have developed a promising new substance for targeting bacteria that cause tuberculosis. The team have produced a compound that inhibits the pathogens’ ability to produce energy and causes them to die. Established drugs work in a similar fashion, but the pathogen is becoming increasingly resistant to these medications. The study was conducted jointly with other researchers from Germany, the USA and Canada and its findings were published in the “Journal of Medicinal Chemistry”.